- Thermo Fisher Scientific Inc TMO provided initial revenue and earnings guidance for 2022 while reiterating previously disclosed financial guidance for full-year 2021.
- Related: Thermo Fisher's Q2 Earnings Beat Expectations; Raises FY21 Outlook.
- The Company said it anticipates total revenues of $40.3 billion for next year, a 12% increase over its $35.9 billion in revenues expected for 2021.
- Adjusted earnings per share are expected to be $21.16. Wall Street analysts, on average, were projecting $34.3 billion in 2022 revenues and EPS of $19.68.
- Price Action: TMO shares are up 8.06% at $605.61 during the market session on the last check Friday.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in